DuoNeb

This page contains recent news articles, when available, and an overview of DuoNeb but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

New Year brings few changes to neb-med pricing  -  ‎Dec 23, 2009‎
The latest average sales price (ASP) figures include slight decreases for levalbuterol (J7614), down 4 cents to 49 cents per dose; and generic DuoNeb ... HME News (blog)

Washington Knows Best  -  ‎Dec 30, 2009‎
The case involved Ilene Hays, a Medicare Part B beneficiary, who had been taking the prescription drug DuoNeb for approximately four years under the advice ... American Spectator

Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32  -  ‎Oct 29, 2009‎
Increased sales of the EpiPen Auto-Injector and Perforomist Solution in the current year were partially offset by lower sales of DuoNeb® as a result of the ... Reuters

Teva gets FDA OK for generic of Dey's DuoNeb  -  Jan 2, 2008
Jan 2 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd (TEVA.O) (TEVA.TA) said the US Food and Drug Administration gave final approval for a generic ... Reuters

Merck Generics valuation to be hit as Duoneb patent ends  -  Mar 2, 2007
MUMBAI: Merck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for the ... Economic Times

Watson gets FDA approval for generic DuoNeb  -  Jan 2, 2008
Jan 2 (Reuters) - Watson Pharmaceuticals Inc (WPI.N) said US health regulators have approved its generic version of Dey LP's DuoNeb for treatment of ... Reuters

First-Time Generic Approvals: Inderal LA, Duragesic-12, DuoNeb  -  Feb 6, 2007
February 6, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for propanolol HCl 60-, 80-, 120-, ... Medscape

Watson to Sell Generic DuoNeb  -  Jan 11, 2008
The FDA has granted final approval to Watson Pharmaceuticals' abbreviated new drug application for generic DuoNeb. Dey's DuoNeb (ipratropium ... FDA news - FDA news (subscription)

Watson Receives FDA Approval For Generic DuoNeb  -  Jan 4, 2008
Watson Pharmaceuticals has received final approval from FDA on its Abbreviated New Drug Application (ANDA) for Ipratropium Bromide and Albuterol Sulfate ... emaxhealth.com

PARI Celebrates 100 Years of Aerosol Therapy.  -  May 17, 2006
...process including Pulmicort Respules by AstraZeneca; Xopenex by Sepracor; Accuneb and DuoNeb by Dey LP; Pulmozyme by Genentech; and TOBI from Chiron. ... Free with registration - PR Newswire - AccessMyLibrary.com

Severe Asthma  -  Dec 11, 2007
I'm 30 w/ severe asthma - I take Advair, Zyflo, Zrytec, Sprivia, Prednisone, Albuterol/Atrovent (DuoNeb), Allergy Shots (weekly) Ativan and I am waiting on ... HealthCentral.com

Ruling Limits Medicare's Ability to Set Drug Prices  -  Dec 1, 2008
The patient, Ilene Hays, had received a prescription for DuoNeb, a combination inhalation drug made by Mylan's Dey subsidiary. ... Psychiatric Times

… : Watson Receives FDA Approval for Generic DuoNeb(R). - PR Newswire...  -  Jan 2, 2008
Watson Receives FDA Approval for Generic DuoNeb(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Loislaw Federal District Court Opinions - IHAYS v. LEAVITT (DC 10-16-...  -  Oct 16, 2008
DuoNeb provides a combination of albuterol and ipratropium bromide in one dose. ... Until recently, the inhalation drug DuoNeb was covered under the Act ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Indian firms out of Merck's picture  -  May 2, 2007
Merck, in its latest annual report, said it expects a sharp decline in sales of DuoNeb. The drug lost market exclusivity in the US with Sandoz AG obtaining ... Livemint

COPD; Symposium offers guidance on COPD best clinical practices  -  Jan 3, 2005
Specifically, this one study suggests that DuoNeb administered as a single therapy ... DEY, LP is the maker of DuoNeb, a nebulized combination product of ... Pay-Per-View - Respiratory Therapeutics Week - Factiva, from Dow Jones

COPD; Symposium offers guidance on COPD best clinical practices  -  Jan 7, 2005
Specifically, this one study suggests that DuoNeb administered as a single therapy ... DEY, LP is the maker of DuoNeb, a nebulized combination product of ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

COPD; Symposium offers guidance on COPD best clinical practices  -  Jan 4, 2005
Specifically, this one study suggests that DuoNeb administered as a single therapy ... DEY, LP is the maker of DuoNeb, a nebulized combination product of ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Cipla, PEs team up for Merck's biz  -  Mar 16, 2007
Furthermore, Merck's generic business is likely to take a new hit as its blockbuster drug, Duoneb, loses market exclusivity in the US. ... Economic Times

Loislaw Federal District Court Opinions - DEY v. EON LABS, INC....  -  Dec 22, 2005
Dey received FDA approval for the Page 4 inhalation solution, "DuoNeb," in the late 1990s. Dey subsequently filed a patent application with the US Patent ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Ahead of the Bell: Lincare Holdings  -  Jun 26, 2008
The cuts to DuoNeb reimbursement are now scheduled to go into effect November 1, but Bonello said they could be delayed further than that. ... Boston Globe

Q1 2006 Merck KGaA Earnings Conference Call - Final.  -  Apr 27, 2006
And if it's EpiPen and Duoneb is the reason that you're only confident for the first part of the year because of what may happen with Duoneb going forwards? ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Press Release: Dey, LP Settles State of Alabama Pricing Litigation. -...  -  Jan 9, 2008
The Web sites for Dey include http://www.dey.com/, http://www.duoneb.com/, http ... 212-880-5263, for Dey Web Site: http://www.dey.com/ ... Pay-Per-View - PR Newswire - HighBeam Research

Ranbaxy Drops Bid For Merck Generics Unit  -  Mar 20, 2007
The firm won FDA approval for a generic version of Duoneb in December. At least one Indian firm may remain in the running to buy the Merck unit. ... Forbes

Preliminary 2006 Merck KGaA Earnings Conference Call - Part 2.  -  Jan 1, 2007
DANI SAURYMPER: Just a quick follow-up on the DuoNeb comment with regards to ... ELMAR SCHNEE: Regarding DuoNeb, we will not gave any details towards the ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

טבע קיבלה ×?ישור FDA לשיווק 2 תרופות גנריות  -  Jan 3, 2008
...מדובר ב×?ישור לשיווק גרסה גנרית של DuoNeb ... מכירות תרופת ×”-DuoNeb של חברת Dey הסתכמו בשנה ... ynet ידיעות ×?חרונות - ynet ידיעות ×?חרונות

FDA cracks down on the unauthorised production of inhalation drugs  -  Aug 14, 2006
...which is essentially a copy of the bronchodilator DuoNeb made by Merck KGaA, ... benzalkonium chloride whereas DuoNeb contains edentate disodium, ... In-PharmaTechnologist.com

Rotech Healthcare, Orlando, FL, Aug. 9 (Cincinnati).  -  Aug 1, 2005
The only noteworthy difference, FDA said, was that Pulmo-Dose's version contained the preservative benzalkonium chloride, and DuoNeb contains edentate ... Entrepreneur

Least costly alternative medicare payment determinations rejected in ...  -  Dec 1, 2008
Her physician had prescribed DuoNeb, an inhalation drug manufactured by Dey, LP, that provides a one dose combination of two drugs, albuterol and ... Pay-Per-View - Healthcare Financial Management - HighBeam Research

Rotech Healthcare, Orlando, FL, Aug. 9 (Cincinnati).(HUMAN DRUGS & …  -  Sep 1, 2006
The only noteworthy difference, FDA said, was that Pulmo-Dose's version contained the preservative benzalkonium chloride, and DuoNeb contains edentate ... $4.95 - Warning Letter Bulletin - ECNext

Press Release: FDA Approves Cyanokit(R) for Treatment of Cyanide …  -  Dec 18, 2006
PR Newswire; January 9, 2008 ; 700+ words ... ... http://www.curosurfusa.com/, http://www.cyanokit.com/, http://www.duoneb.com/, http://www ... com/ ... Pay-Per-View - PR Newswire - HighBeam Research

Loislaw Federal District Court Opinions - DEY, LP v. IVAX …  -  Nov 10, 2005
...of studies conducted in November 2003 and May 2005 comparing DuoNeb to Combivent products, (3) failing to reveal the identity of the inventor of DuoNeb, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Mylan deal shows generic drugs going global  -  May 14, 2007
On the basis of expected earnings it is even pricier, since Merck's Duoneb product is about to lose exclusivity, which will hit profit margins. ... Reuters

Merck in-line (Goldman Sachs) | Analyse | finanzen.net  -  Feb 10, 2006
Ein weiteres Risiko sehe man in der Markteinführung einer Nachahmerversion von "DuoNeb". Nach Schätzung der Analysten habe "DuoNeb" im Jahr 2005 8% zum EBIT ... FINANZEN.NET NEWS - FINANZEN.NET NEWS

Citigroup: Merck KGaA's generics "dream fit" for Teva: The bank …  -  Jan 11, 2007
In the US, the portfolio overlap is small because most of Merck KGaA's 2005 sales of $590 million were in the inhaler DuoNeb ($310 million) and the ... Pay-Per-View - Globes - HighBeam Research

FDA warns manufacturers of compounded drugs: traditional …  -  Oct 1, 2006
...which is "essentially a copy of the commercially available product DuoNeb." Although the two products contain different preservatives, prescriptions for ... Free with registration - Internal Medicine News - AccessMyLibrary.com

DEY, LP Donates $100,000 and Medications for Hurricane Katrina …  -  Sep 14, 2005
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/; http://www.curosurf.com/, http://www.duoneb.com/ and http://www.epipen.com/. ... $4.95 - PR Newswire - ECNext

Court Blocks White House Push on Medicare Expenses  -  Nov 3, 2008
Judge Kennedy found that Medicare and some of its contractors had unlawfully limited payments for DuoNeb, an inhalation drug taken through a nebulizer, ... New York Times

Serono sold.(RX RETAIL PHARMACY: Branded Drugs)(Merck KGaA …  -  Jan 22, 2007
Article: DuoNeb approved.(Merck KGAA)(Brief Article) Chain Drug Review; April 23, 2001 ; 565 words ...The FDA has approved the first dual-therapy nebulizer ... Pay-Per-View - Chain Drug Review - HighBeam Research

«Тева» шагнула в 2008 год Ñ? правой ноги  -  Jan 3, 2008
ПерваÑ? из полученных лицензий – на Ñ?быт аналога препарата DuoNeb – Ñ?кÑ?тракта длÑ? ингалÑ?ций производÑ?тва компании «Dey» (годовой объем продаж оригинала – 265 ... ИзраильÑ?кие новоÑ?ти

A warning on asthma drugs, Mass-marketed drug compounds sold for …  -  Mar 14, 2006
...manufactured by Nephron Pharmaceuticals and Warrick Pharmaceuticals; Xopenex, a product of Sepracor Inc.; DuoNeb by Dey LP; and Pulmicort Respules, ... Pay-Per-View - Newsday - ProQuest Archiver

Indian company best fit for Merck Generics  -  Feb 26, 2007
Merck Generics' US affiliate, Dey, which had sales of euro 436 million in 2005, has a strong respiratory products portfolio that includes DuoNeb, EpiPen and ... Rediff

Movers: Intel, Starbucks, Akeena Solar, LDK Solar, Amazon.com  -  Jan 2, 2008
...the generic equivalent to Dey, LP's DuoNeb, which is indicated for treatment of bronchospasm associated with chronic obstructive pulmonary disease ... BusinessWeek

Actavis Weighs Bid on Merck KGaA's Generic Drugs Unit  -  Jan 26, 2007
The value hinges on whether Merck loses its exclusive US sales rights on its DuoNeb treatment for smoker's cough, she said. Merck settled with unnamed ... Bloomberg

FDA warns 3 compounders of inhalation drugs.(Clinical Rounds)  -  Sep 1, 2006
Inc.) manufactures albuterol 2.5 mg/ipratropium 0.5 mg in 3-mg vials, which is "essentially a copy of the commercially available product DuoNeb." ... Free with registration - Pediatric News - AccessMyLibrary.com

Mylan Rally Has Legs  -  Dec 12, 2008
Its two key products are the EpiPen, the most-prescribed epinephrine auto-injector for the treatment of severe allergic reactions, and DuoNeb, a nebulized ... Forbes

Drug Company Settles Price-Fixing Case in Connecticut  -  Jul 20, 2005
The company has promised to donate more than 2 million vials of DuoNeb, Albuterol and Ipratropium Bromide -- all treatments for respiratory ailments such as ... RedOrbit

Stada Is Exploring Merck Generics Bid, People Say  -  Mar 6, 2007
...is expected to slow later this year when it loses patent protection on one of its biggest products, Duoneb for smokers' cough, the Eczacibasi purchase ... Bloomberg

FDA warns compounders of inhaled budesonide.(News)  -  Sep 15, 2006
...which is "essentially a copy of the commercially available product DuoNeb." Although the two products contain different preservatives, prescriptions for ... Free with registration - Family Practice News - AccessMyLibrary.com

World COPD Day: 12 Million Americans Unaware They Are at Risk for …  -  Nov 16, 2005
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurf.com/, http://www.duoneb.com/ and http://www.epipen.com/. ... $4.95 - PR Newswire - ECNext

Ranbaxy sees synergy dose in Merck unit  -  Jan 10, 2007
Merck's applications include top selling prescription drugs like albuterol, piroxicam and duoneb used for treating asthma, arthritis and lung disorders, ... Pay-Per-View - Economic Times - Factiva, from Dow Jones

FDA warns firms to stop making knockoffs of inhalation meds  -  Dec 12, 2006
Since at this time there are no FDA-approved generic forms of Pulmicort Respules, Xopenex or DuoNeb, any generic substitution for these medications is an ... AAP News - AAP News (subscription)

Dey, LP Reaches Settlement with State of Connecticut on Pricing …  -  Jul 19, 2005
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurf.com/, http://www.duoneb.com/, http://www.epipen.com/ . $4.95 - PR Newswire - ECNext

Tysen to be featured at CMN fund-raiser  -  Mar 2, 2006
He also takes as many as eight treatments a day of Albuterol or DuoNeb, an inhaled medication from a nebulizer to help him with his breathing and to help ... West Salem Coulee News

Merck consolidates US generics.(COMPANY NEWS)(Brief Article)  -  Oct 1, 2005
The company already derives 31% of its total generics sales from the US market, predominantly stemming from the duoNeb and EpiPen, supergeneric respiratory ... $4.95 - Pharmaceutical Technology Europe - ECNext

Jefferies & Co Downgrades Rotech Healthcare Inc. (ROHI) To …  -  Apr 26, 2006
Also, there is belief that additional reimbursement cuts could be coming, particularly in inhalation drugs like Xopenex an DuoNeb. ... StreetInsider.com - StreetInsider.com (subscription)

FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for …  -  May 31, 2007
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.cyanokit.com/, http://www.duoneb.com/, ... Free with registration - PR Newswire - AccessMyLibrary.com

DEY, LP Donates $100,000 to the American Red Cross Tsunami Disaster …  -  Jan 3, 2005
The Web sites for DEY include http://www.dey.com/, http://www.duoneb.com/ and http://www.epipen.com/. DEY is an affiliate of Merck KGaA, Darmstadt, Germany. $4.95 - PR Newswire - ECNext

Full Year 2005 Merck KGaA Analysts' Conference - Final.  -  Feb 16, 2006
Other, our DuoNeb in -- from PayLab in California did develop over the last year to one of our top-selling products. This was really a highlight. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

×?ושר שיווק תרופות גנריות חדשות גלי צה"ל ×?ון ליין  -  Jan 6, 2008
...×”×?ישור הר×?שון הו×? לשיווק גרסה גנרית של DuoNeb - תמיסה לטיפול ההרחבת הסימפונות ו×?ילו ... גלי צה״ל

Russell v. Alcoa, Inc., No. 3:CV-06-1459 (MDPa. 03/31/2008)  -  Mar 31, 2008
In addition to the Vicodin, Cymbalta and Tylenol that Mr. Russell was already taking for pain, Dr. Ivor prescribed Combivent, Nebulizer, DuoNeb and Avelox. ... $2.95 - U.S. District Court, Middle District of... - VersusLaw

Critical Therapeutics and DEY, LP Enter into Co-Promotion Agreement...  -  Mar 14, 2007
The Web sites for DEY include www.dey.com, www.accuneb.com, www.curosurfusa.com, www.duoneb.com, www.epipen.com. DEY is an affiliate of Merck KGaA, ... Free with registration - Business Wire - AccessMyLibrary.com

StayinFront and Dey LP Expand Partnership with New Hospital Sales …  -  Jul 22, 2005
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurf.com/, http://www.duoneb.com/, http://www.epipen.com/. ... $4.95 - PR Newswire - ECNext

Ranbaxy shares gain 6 pc on decision to pull out of Merck bid  -  Mar 20, 2007
...in 2007 as the German company is scheduled to lose patent protection for one of its biggest product Duoneb -- a cough medicine prescribed to smokers. ... Free with registration - PTI - The Press Trust of India Ltd - AccessMyLibrary.com

Dey LP and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) ( …  -  Sep 27, 2007
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.cyanokit.com/, http://www.duoneb.com/, ... Free with registration - PR Newswire - AccessMyLibrary.com

Foolish Forecast: My, Oh, Mylan  -  May 17, 2007
Margins at the Merck business will also be impacted by loss of exclusivity on its main drug, Duoneb, which could make integrating this unit a challenge. fool.com

Dey, LP Names Christy Taylor New SVP for Sales, Marketing and …  -  Feb 14, 2006
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.duoneb.com/ and http://www.epipen.com/. ... Free with registration - PR Newswire - AccessMyLibrary.com

Mylan Inc. Subsidiary, Dey, LP, Announces that Perforomist(TM) ( …  -  Oct 8, 2007
...next generation product, which we believe will substantially replace the sales resulting from the loss of exclusivity of DuoNeb(R) Inhalation Solution. ... Free with registration - PR Newswire - AccessMyLibrary.com

Preterm Infants with Respiratory Distress Syndrome: Incidence Rates...  -  May 7, 2007
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.cyanokit.com/, http://www.duoneb.com/, ... Free with registration - PR Newswire - AccessMyLibrary.com

Data from Three Clinical Trials for Perforomist(TM) Inhalation...  -  Oct 16, 2007
...http://www.curosurfusa.com/, http://www.cyanokit.com/, http://www.duoneb.com/, http://www.epipen.com/ and http://www.perforomist.com/. ... Free with registration - PR Newswire - AccessMyLibrary.com

Clinical Trial Data on the Safety and Efficacy of Concomitant...  -  Oct 24, 2007
...http://www.curosurfusa.com/, http://www.cyanokit.com/, http://www.duoneb.com/, http://www.epipen.com/ and http://www.perforomist.com/. ... Free with registration - PR Newswire - AccessMyLibrary.com

Dey, LP Reaches Settlement with Commonwealth of Massachusetts on …  -  Apr 24, 2007
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.cyanokit.com/, http://www.duoneb.com/, ... Free with registration - PR Newswire - AccessMyLibrary.com

Florida EMS and fire vehicles to stock Cyanokit 5g antidote for...  -  May 29, 2008
The Web sites for Dey, LP include www.dey.com, www.accuneb.com, www.curosurfusa.com, www.cyanokit.com, www.duoneb.com, www.epipen.com and ... eurekalert.org

Dey LP And Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) ( …  -  Sep 28, 2007
The Web sites for DEY include http://www.dey.com, http://www.accuneb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com, ... Medical News Today - Medical News Today (press release)

First-time generic approvals.(FDA Drug Approvals)(Brief article)  -  Feb 1, 2007
Albuterol and ipratropium inhalation solution, 3 mg (0.083%) and 0.5 mg (0.017%) in 3-mL vials (equiv to DuoNeb inhalation solution) SANDOZ. Free with registration - Formulary - AccessMyLibrary.com

Apria Healthcare "equal weight," target price reduced  -  Oct 14, 2008
By indicating that the recent cuts in Medicare reimbursement for DuoNeb would have a greater-than-expected impact on its 2008 revenues, Apria Healthcare has ... newratings.com

New Data on Perforomist(TM) Inhalation Solution to Be Presented at …  -  Oct 24, 2008
...http://www.curosurfusa.com/, http://www.cyanokit.com/, http://www.duoneb.com/, http://www.epipen.com/ and http://www.perforomist.com/. ... RedOrbit

Dey Inc. settles the claim it inflated wholesale Medicaid and...  -  Mar 25, 2007
...for the treatment of respiratory diseases and respiratory related allergies. Its drugs include Albuterol, Cromolyn Sodium, Duoneb, Epipen and Ipratroprium. Honolulu Star-Bulletin

Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged …  -  Oct 29, 2008
The Web sites for Dey, LP include http://www.dey.com, http://www.accuneb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com, ... International Business Times

Medications scheduled to come off patent in 2007 *.(Drug and Formulary...  -  Feb 1, 2007
Medication Brand name 2005 retail sales (US$) Albuterol/ipratropium DuoNeb $161 million Amlodipine Norvasc $2060 million Amlodipine/benazepril Lotrel $1110 ... Free with registration - Formulary - AccessMyLibrary.com

Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY …  -  Feb 19, 2007
166443 13.2 169 Klor-Con 163286 -7.1 170 Humulin N 163208 -3.1 171 DuoNeb 162376 0.7 172 Famvir 160602 -1.7 173 Proscar 160135 -33.0 174 Neupogen 159279 ... Free with registration - Drug Topics - AccessMyLibrary.com

Dey, LP Reaches Settlement with State of Hawaii on Pricing Litigation.  -  Mar 21, 2007
The Web sites for DEY include http://www.dey.com, http://www.accuneb.com, http://www.curosurfusa.com, http://www.duoneb.com, http://www.epipen.com. Media ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Merck KGaA 2nd-qtr as expected.  -  Aug 1, 2005
In fact, the success of its bestseller in the USA, the DuoNeb (albuterol and ipratropium) inhaler for treating chronic obstructive pulmonary disease, ... $4.95 - Pharma Marketletter - ECNext

Merck KGaA's Net Declines 21%  -  Oct 24, 2006
The company didn't release any further news on a patent challenging case regarding Merck's generic drug Duoneb, one of its best-selling generic drugs to ... Subscription - Wall Street Journal Online - Dow Jones & Company

Respiratory Drug Fee Schedule Reflects New Utilization Trends  -  Jun 27, 2005
There was some confusion when CMS posted the quarterly fee schedule update with an error for the albuterol compound solution (DuoNeb). ... Pay-Per-View - Primedia Insight - Factiva, from Dow Jones

Statement from Dey, LP Regarding Pricing Litigation by the US …  -  Sep 11, 2006
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.duoneb.com/, and http://www.epipen.com/. ... $4.95 - PR Newswire - ECNext

Steady stream of new products hits market.  -  Feb 4, 2008
Teva Pharmaceutical Industries Ltd. says its ANDA for generic DuoNeb (Dey Laboratories Inc.) has been approved. Recognized by its generic name of albuterol ... $9.94 - Chain Drug Review - Alacra Store

First-time generic approvals.  -  Feb 1, 2007
Albuterol and ipratropium inhalation solution, 3 mg (0.083%) and 0.5 mg (0.017%) in 3-mL vials (equiv to DuoNeb inhalation solution) ... $9.94 - Formulary - Alacra Store

Sun acquisition.(News)(Sun Pharmaceutical Industries Ltd. acquires …  -  Dec 8, 2008
Ltd. is launching oxcarbazepine in the ... country total about $700 million. Teva Pharmaceutical Industries Ltd. says its ANDA for generic DuoNeb ... ... Pay-Per-View - Chain Drug Review - HighBeam Research

Bronchodilator: short-acting beta2-agonist.(Pediatric Advisor...  -  Nov 1, 2006
Combivent and DuoNeb contain both a short-acting beta 2-agonist (albuterol) and an anticholinergic (ipratropium bromide). Nebulizer: Albuterol comes in 3 ml ... $4.95 - Clinical Reference Systems - ECNext

Press Release: Statement from Dey, LP Regarding Pricing Litigation by...  -  Sep 11, 2006
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.duoneb.com/, and http://www.epipen.com/. ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: PARI Respiratory's LC PLUS & PRONEB Ultra Deliver …  -  Oct 9, 2007
PARI's nebulizers and compressors are the top performers in the industry, which makes them a perfect fit for many of DEY's products -- including DuoNeb, ... Pay-Per-View - PR Newswire - HighBeam Research

FDA warns 3 compounders of inhalation drugs.(Clinical Rounds) |...  -  Sep 1, 2006
Inc.) manufactures albuterol 2.5 mg/ipratropium 0.5 mg in 3-mg vials, which is "essentially a copy of the commercially available product DuoNeb." ... Pay-Per-View - Pediatric News - HighBeam Research

CMS Issues Draft Local Coverage Determination for Nebulizers  -  Apr 3, 2006
...--Payment for levalbuterol will be based on the allowance for albuterol; --Payment for DuoNeb will be based on the allowance for separate unit dose vials of ... Pay-Per-View - Primedia Insight - Factiva, from Dow Jones

Press Release: Dey, LP Reaches Settlement with State of Connecticut...  -  Jul 19, 2005
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurf.com/, http://www.duoneb.com/, http://www.epipen.com/ . ... Pay-Per-View - PR Newswire - HighBeam Research

PHARMACIES, DME SUPPLIERS PROTEST ATTEMPT TO LOWER …  -  Jun 1, 2006
...on the reimbursement amount for albuterol, and base payment for DuoNeb on the allowance for separate unit dose vials of albuterol and ipratropium. ... Pay-Per-View - Inside CMS - Factiva, from Dow Jones

FDA warns compounders of inhaled budesonide.(News) | Article from …  -  Sep 15, 2006
...which is "essentially a copy of the commercially available product DuoNeb." Although the two products contain different preservatives, prescriptions for ... Pay-Per-View - Family Practice News - HighBeam Research

Dey, LP Reaches Settlement with State of Ohio on Pricing Litigation.  -  Nov 28, 2006
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.duoneb.com/, http://www.epipen.com/. $4.95 - PR Newswire - ECNext

EDITED BRIEF  -  May 8, 2008
Within specialty segment, sales of DuoNeb decreased as a result of generic competition on the product. a. As expected, multiple generic competitors entered ... $54.00 - Thomson StreetEvents - Alacra Store

First-time generic approvals.(FDA Drug Approvals)(Brief article)  -  Feb 1, 2007
Albuterol and ipratropium inhalation solution, 3 mg (0.083%) and 0.5 mg (0.017%) in 3-mL vials (equiv to DuoNeb inhalation solution) ... $4.95 - Formulary - ECNext

Press Release: PARI Celebrates 100 Years of Aerosol Therapy. - PR …  -  May 17, 2006
...process including Pulmicort Respules by AstraZeneca; Xopenex by Sepracor; Accuneb and DuoNeb by Dey LP; Pulmozyme by Genentech; and TOBI from Chiron. ... Pay-Per-View - PR Newswire - HighBeam Research

Dey, LP Reaches Settlement with State of Nevada on Pricing Litigation.  -  Mar 29, 2007
The Web sites for DEY include http://www.dey.com/, http://www.accuneb.com/, http://www.curosurfusa.com/, http://www.duoneb.com/, and http://www.epipen.com/. ... $4.95 - PR Newswire - ECNext

CMS: XOPONEX NATIONAL COVERAGE DECISION IN THE WORKS  -  Dec 28, 2006
...made by all four Durable Medical Equipment Program Safeguard Contractors (DMEPSCs) reduced payment for the drug and the nebulizer (DuoNeb). ... Pay-Per-View - Inside CMS - Factiva, from Dow Jones





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy